Cell Impact AB (publ) (STO:CI)
Sweden · Delayed Price · Currency is SEK 0.0680
-0.0019 (-2.72%)
Jul 24, 2026, 5:29 PM CET
Cell Impact AB Cash Flow Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -123.7 | -127.92 | -99.02 | -119.49 | -103.47 | -78.04 |
Depreciation & Amortization | 76.97 | 109.82 | 72.17 | 25.31 | 16.44 | 10.01 |
Other Adjustments | -1.77 | 47.35 | 18.31 | -0.73 | -1.37 | -1.31 |
Change in Receivables | - | -0.03 | -0.58 | 17.09 | 50.82 | - |
Changes in Inventories | 4.59 | 4.1 | 10.85 | -24.76 | -24.62 | -13.57 |
Changes in Accounts Payable | - | 2.79 | -7.7 | -4.05 | -1.77 | - |
Changes in Other Operating Activities | -0.39 | -1.79 | -10.44 | 0.81 | -41.97 | -3.16 |
Operating Cash Flow | -44.3 | -45.36 | -62.23 | -105.83 | -105.93 | -86.08 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Capital Expenditures | -1.46 | -1.93 | -12.4 | -50.46 | -62.44 | -52.97 |
Sale of Property, Plant & Equipment | - | 4.23 | - | - | - | - |
Purchases of Intangible Assets | - | - | -2.02 | -2.99 | -5.95 | -1.34 |
Purchases of Investments | - | 0 | -0 | 0 | -0 | -0.01 |
Investing Cash Flow | 2.77 | 2.3 | -14.43 | -53.46 | -68.4 | -54.32 |
Long-Term Debt Issued | 22.21 | 22.21 | - | - | 30 | 20 |
Long-Term Debt Repaid | -16.88 | -18.9 | -8.21 | -8.21 | -2.59 | -1.21 |
Net Long-Term Debt Issued (Repaid) | 5.33 | 3.31 | -8.21 | -8.21 | 27.41 | 18.79 |
Issuance of Common Stock | 46.45 | 39.23 | 17.82 | 128.91 | 331.22 | - |
Net Common Stock Issued (Repurchased) | 46.45 | 39.23 | 17.82 | 128.91 | 331.22 | - |
Other Financing Activities | -12.03 | -8.85 | -12.44 | -26.08 | -48.16 | -1.78 |
Financing Cash Flow | 39.75 | 33.68 | -2.84 | 94.62 | 310.47 | 17.01 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | -0.1 | -0.15 | -0.01 | -0.11 | -0.03 | 0.02 |
Net Cash Flow | -1.78 | -9.38 | -79.5 | -64.67 | 136.14 | -123.39 |
Free Cash Flow | -45.76 | -47.29 | -74.64 | -156.29 | -168.37 | -139.05 |
Free Cash Flow Growth | - | - | - | - | - | - |
FCF Margin | -1100.79% | -2290.07% | -278.02% | -321.75% | -180.98% | -169.99% |
Free Cash Flow Per Share | -0.21 | -0.28 | -0.44 | -14.26 | -22.23 | -23.48 |
Levered Free Cash Flow | -43.89 | -15.69 | -56.17 | -182.77 | -191.16 | -120.76 |
Unlevered Free Cash Flow | -43.95 | -14.92 | -46.46 | -172.61 | -217.75 | -137.62 |